Onconetix Inc (ONCE) Stock Price & Overview

NASDAQ:ONCE

Current stock price

113.57 USD
+2.82 (+2.55%)
At close:
114.48 USD
+0.91 (+0.8%)
Pre-Market:

The current stock price of ONCE is 113.57 USD. Today ONCE is up by 2.55%. In the past month the price increased by 2.49%. In the past year, price increased by 206.86%.

ONCE Key Statistics

52-Week Range34.53 - 114.2
Current ONCE stock price positioned within its 52-week range.
1-Month Range109.25 - 113.9
Current ONCE stock price positioned within its 1-month range.
Market Cap
4.375B
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-6.56
Dividend Yield
N/A

ONCE Stock Performance

Today
+2.55%
1 Week
+2.19%
1 Month
+2.49%
3 Months
+10.95%
Longer-term
6 Months +8.09%
1 Year +206.86%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

ONCE Stock Chart

Onconetix Inc / ONCE Daily stock chart

ONCE Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to ONCE. When comparing the yearly performance of all stocks, ONCE is one of the better performing stocks in the market, outperforming 98.44% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ONCE Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ONCE. ONCE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ONCE Earnings

Next Earnings DateN/A
Last Earnings DateN/A

ONCE Forecast & Estimates


Analysts
Analysts60
Price TargetN/A
EPS Next Y-151.66%
Revenue Next YearN/A

ONCE Financial Highlights

Over the last trailing twelve months ONCE reported a non-GAAP Earnings per Share(EPS) of -6.56. The EPS decreased by -202.3% compared to the year before.


Income Statements
Revenue(TTM)69.88M
Net Income(TTM)-250.45M
Industry RankSector Rank
PM (TTM) -358.41%
ROA -35.6%
ROE N/A
Debt/Equity 0.35
Chartmill High Growth Momentum
EPS Q2Q%-36.51%
Sales Q2Q%109.65%
EPS 1Y (TTM)-202.3%
Revenue 1Y (TTM)18.48%

ONCE Ownership

Ownership
Inst Owners88.37%
Shares38.52M
Float28.00M
Ins Owners82.34%
Short Float %N/A
Short RatioN/A

About ONCE

Company Profile

Spark Therapeutics, Inc. offers gene therapy. The Company's product candidate consist of SPK-RPE65, SPK-CHM, SPK-FIX which are in different clinical phases, for the treatment of additional blinding conditions, hematologic disorders and neurodegenerative diseases. Spark Therapeutics, Inc. is based in Philadelphia, Pennsylvania.

Company Info

Onconetix Inc

3737 MARKET STREET SUITE 1300

PHILADELPHIA PA 19104

CEO: Jeffrey D. Marrazzo

Phone: 888-772-7560

Onconetix Inc / ONCE FAQ

What does ONCE do?

Spark Therapeutics, Inc. offers gene therapy. The Company's product candidate consist of SPK-RPE65, SPK-CHM, SPK-FIX which are in different clinical phases, for the treatment of additional blinding conditions, hematologic disorders and neurodegenerative diseases. Spark Therapeutics, Inc. is based in Philadelphia, Pennsylvania.


What is the stock price of Onconetix Inc today?

The current stock price of ONCE is 113.57 USD. The price increased by 2.55% in the last trading session.


Does ONCE stock pay dividends?

ONCE does not pay a dividend.


What is the ChartMill technical and fundamental rating of ONCE stock?

ONCE has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the market capitalization of ONCE stock?

Onconetix Inc (ONCE) has a market capitalization of 4.38B USD. This makes ONCE a Mid Cap stock.